Skip to main content
Premium Trial:

Request an Annual Quote

Harry Stylli, Stephen David, Volker Muschalek, Michael Murphy, and Christine Seidman


Harry Stylli has been appointed the new President and CEO of Sequenom, the company said this week. Stylli most recently served as President and CEO of Xencor, where he is still a member of the board of directors. He earned a PhD from the London University's Faculty of Medicine, and an MA in business administration from the UK's Open University.

Stephen David has joined Nonlinear Dynamics' strategic marketing team, the Newcastle upon Tyne, UK-based company said this week. He comes to Nonlinear from GE Healthcare, formerly Amersham Biosciences, where he worked as DiGE global applications specialist.

Volker Muschalek has left MWG Biotech, effective May 31, the company said this week. He was one of two members of the company's management board and in charge of operations, human resources, IT, and the company's India business.

Michael Murphy has become senior vice president of operations of Pacific Biometrics, the company said this week. He joins the Pacific from LabCorp, where he was a technical director. Murphy holds a doctorate in pathology and physiological chemistry from Ohio State University and a BS in natural sciences from Xavier University in Cincinnati.

Christine Seidman has been elected to the National Academy of Sciences, the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics said last week. She is an associate director of HPCGG; director of the cardiovascular genetics service at the Brigham and Women's Hospital in Boston; and a Howard Hughes investigator.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.